JNCCN 360 - Ovarian - Ongoing CE Activities

Advertisement

Advertisement

Ongoing CE Activities

Addressing Persistent Challenges in Treatment and Management of Low-Grade Serous Ovarian Carcinoma to Amplify the Latest Evidence in Emerging Therapies

An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer

Evolution of the Care of Patients With Advanced Ovarian Cancer

Optimal integration of pembrolizumab into the care of patients with metastatic MSI-high/dMMR gynecologic cancers

Research experience with and ongoing evaluation of anti-PD-1/PD-L1 antibodies in combination with chemotherapy or targeted therapy for advanced ovarian cancer

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology

Sections

NCCN Resources

Copyright © 2025 National Comprehensive Cancer Network, All Rights Reserved